Erratum: Smac mimetics: implications for enhancement of targeted therapies in leukemia

Correction to: Leukemia (2010) 25, 2100–2109; doi:10.1038/leu.2010.212 Owing to a typesetting error, the following sentence was incorrectly printed in the abstract section of the article: ‘The novel inhibitor of apoptosis (IAP), LCL161, was observed to potentiate the effects of tyrosine kinase inhib...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2011-07, Vol.25 (7), p.1221-1221
Hauptverfasser:	Weisberg, E, Ray, A, Barrett, R, Nelson, E, Christie, A L, Porter, D, Straub, C, Zawel, L, Daley, J F, Lazo-Kallanian, S, Stone, R, Galinsky, I, Frank, D, Kung, A L, Griffin, J D
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/67/1059/2326 692/699/67/1059/602 692/699/67/1990/283 692/700/565/1436/1437 Cancer Research Critical Care Medicine Erratum Hematology Intensive Internal Medicine Medicine Medicine & Public Health Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Correction to: Leukemia (2010) 25, 2100–2109; doi:10.1038/leu.2010.212 Owing to a typesetting error, the following sentence was incorrectly printed in the abstract section of the article: ‘The novel inhibitor of apoptosis (IAP), LCL161, was observed to potentiate the effects of tyrosine kinase inhibition against leukemic disease both in the absence and presence of a stromal protected environment.
ISSN:	0887-6924 1476-5551
DOI:	10.1038/leu.2011.83